We are pleased to have received further data for the Pfizer/BioNTech COVID-19 vaccine candidate. It is our job now to rigorously assess these data and the evidence submitted on the vaccine’s safety, quality and effectiveness.

We are pleased to have received further data for the Pfizer/BioNTech COVID-19 vaccine candidate. It is our job now to rigorously assess these data and the evidence submitted on the vaccine’s safety, quality and effectiveness.
Tags Medicines and Healthcare Products Regulatory Agency Pfizer Statement
‘To undermine and ransom nature by prioritising the profits of multinational industries is not alright.’The …
The Albanese government will push for a new deal after President Donald Trump announced a …